Oral Presentation The Joint Annual Scientific Meetings of the Endocrine Society of Australia and the Society for Reproductive Biology 2017

Disease modifying therapy in T1D; what an endocrinologist needs to know (#126)

Carla Greenbaum 1
  1. Benaroya Research Institute, Seattle, WA, United States

We can now identify individuals at very early stages of T1D. This alone can prevent dka. But the real issue is to delay progession to clinical disease. Recent trial results are tantalizing.